In addition, the combination of shKDM1A and doxorubicin led to a lower degree of tumor proliferation and more apoptosis, as determined by Ki67 and cleaved caspase 3 staining, respectively (Figure 3F). The gene discussed is CASP3; the disease is neoplasm.